Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Heart Failure IV: Classification and Diagnostic Evaluation01:30

Heart Failure IV: Classification and Diagnostic Evaluation

23
Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
23
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

1.7K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.7K
Heart Failure III: Clinical Manifestations01:26

Heart Failure III: Clinical Manifestations

30
Heart failure (HF) manifests primarily as dyspnea, fatigue, and fluid retention, resulting in peripheral and pulmonary edema. Symptoms may vary depending on which ventricle is more affected, left or right.Left-Sided Heart FailureAlso known as left ventricular failure, this condition results from the left ventricle's inability to fill or eject sufficient blood into the systemic circulation. It leads to pulmonary congestion, which occurs when the left ventricle fails to eject blood effectively...
30
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

19
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
19
Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

18
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
18
Heart Failure I: Introduction01:27

Heart Failure I: Introduction

29
Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
29

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Rivaroxaban for Prevention of Thrombotic Events, Hospitalization, and Death in Outpatients With COVID-19: A Randomized Clinical Trial.

Circulation·2023
Same author

Temporal trends in the prevalence and severity of aortic stenosis within a contemporary and diverse community-based cohort.

International journal of cardiology·2023
Same author

Probing the Association between Acute Kidney Injury and Cardiovascular Outcomes.

Clinical journal of the American Society of Nephrology : CJASN·2023
Same author

Proteomic cardiovascular risk assessment in chronic kidney disease.

European heart journal·2023
Same author

Clinical decision support to Optimize Care of patients with Atrial Fibrillation or flutter in the Emergency department: protocol of a stepped-wedge cluster randomized pragmatic trial (O'CAFÉ trial).

Trials·2023
Same author

Breast arterial calcification is associated with incident atrial fibrillation among older but not younger post-menopausal women.

European heart journal open·2023

Related Experiment Video

Updated: Aug 6, 2025

Cutoff Value of Phase Angle by Bioelectrical Impedance Analysis at Admission as a Prognostic Factor in Patients with Acute Heart Failure
05:15

Cutoff Value of Phase Angle by Bioelectrical Impedance Analysis at Admission as a Prognostic Factor in Patients with Acute Heart Failure

Published on: June 10, 2025

156

Approach to Multimorbidity Burden Classification and Outcomes in Older Adults With Heart Failure.

Mayra Tisminetzky1,2,3, Jerry H Gurwitz1,2,3, Grace Tabada4

  • 1Meyers Health Care Institute, a Joint Endeavor of University of Massachusetts Chan Medical School, Reliant Medical Group, and Fallon Health.

Medical Care
|March 15, 2023
PubMed
Summary

Simple chronic condition counts effectively predict outcomes in heart failure (HF) patients, similar to complex scores. This finding simplifies multimorbidity assessment in real-world studies of beta-blocker therapy.

More Related Videos

Author Spotlight: Workflow for Integrating POCUS Data into EHR for Managing Heart Failure Patients
03:47

Author Spotlight: Workflow for Integrating POCUS Data into EHR for Managing Heart Failure Patients

Published on: July 12, 2024

849
Multidisciplinary Approach to Obesity Management: A Case Report
05:10

Multidisciplinary Approach to Obesity Management: A Case Report

Published on: May 30, 2025

253

Related Experiment Videos

Last Updated: Aug 6, 2025

Cutoff Value of Phase Angle by Bioelectrical Impedance Analysis at Admission as a Prognostic Factor in Patients with Acute Heart Failure
05:15

Cutoff Value of Phase Angle by Bioelectrical Impedance Analysis at Admission as a Prognostic Factor in Patients with Acute Heart Failure

Published on: June 10, 2025

156
Author Spotlight: Workflow for Integrating POCUS Data into EHR for Managing Heart Failure Patients
03:47

Author Spotlight: Workflow for Integrating POCUS Data into EHR for Managing Heart Failure Patients

Published on: July 12, 2024

849
Multidisciplinary Approach to Obesity Management: A Case Report
05:10

Multidisciplinary Approach to Obesity Management: A Case Report

Published on: May 30, 2025

253

Area of Science:

  • Clinical Research
  • Real-World Evidence
  • Cardiology

Background:

  • Assessing multimorbidity burden in real-world data for treatment outcomes is challenging.
  • The optimal method for characterizing multimorbidity in heart failure (HF) patients remains unclear.
  • This study investigates how different multimorbidity measurements affect observed associations with beta-blocker use in HF.

Purpose of the Study:

  • To compare two distinct approaches for measuring multimorbidity burden.
  • To determine if simple chronic condition counts or weighted scores better predict outcomes in HF patients on beta-blockers.
  • To assess the influence of multimorbidity characterization on the association between beta-blocker use and clinical outcomes.

Main Methods:

  • Retrospective study of adult HF patients from four integrated health care systems.
  • Multimorbidity burden was measured using simple chronic condition counts and a weighted multiple chronic conditions score.
  • Associations between beta-blocker use and all-cause death, HF hospitalization, and any-cause hospitalization were analyzed.

Main Results:

  • The study included over 9,900 HF patients in each characterization group, with similar demographics.
  • Multivariable analyses showed comparable risks of death and hospitalization associated with beta-blocker use, irrespective of the multimorbidity measurement method.
  • Both simple counts and weighted scores demonstrated similar predictive performance for clinical outcomes.

Conclusions:

  • Simple chronic condition counts are as effective as weighted multimorbidity scores for predicting outcomes in real-world HF data.
  • These findings suggest that complex multimorbidity measures may not always be necessary for observational studies on therapy-associated outcomes.
  • The study provides evidence for a simplified approach to multimorbidity assessment in clinical research involving beta-blocker therapy in heart failure.